July 12, 2025 | 10:21 am
Most pharmaceutical companies selling to the US market could not survive a 200 per cent tariff, according to a leading economist.
Earlier this week, the US president threatened sweeping tariffs of up to 200 percent on pharmaceutical products made outside the United States.
Dan O’Brien, Chief Economist of the Institute of International and European Affairs, says it would be devastating.
The competition is for young people from across Connacht.
read more
It means the deal could be delayed for a number of years.
read more
Over 7,000 jobs were created nationally last year through LEO financial supports
read more
Councillor Sheridan is calling on the Minister for Transport to come to Mayo and explain it.
read more
"Yesterday’s vote is disappointing"
read more